Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This study is a double-blind, placebo-controlled, randomized clinical trial to determine
whether IVIG is effective in improving motor scores in patients with myasthenia gravis and
worsening weakness.